Related Experiment Video
Updated: Sep 1, 2025

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
The predictive value of MAPH score for determining thrombus burden in patients with non-ST segment elevation
Özge Çakmak Karaaslan1, Cem Çöteli2, Murat Oğuz Özilhan3
1Department of Cardiology, Ankara Bilkent City Hospital, Health Sciences University, Ankara, Turkey. ozgecakmak2323@gmail.com.
Insights
The MAPH score, using mean platelet volume, age, total protein, and hematocrit, effectively predicts high thrombus burden in non-ST segment elevation myocardial infarction (NSTEMI) patients. This accessible score aids in assessing cardiovascular risk.
Area of Science:
- Cardiology
- Hematology
- Biomedical Engineering
Background:
- High thrombus burden is linked to adverse outcomes in non-ST segment elevation myocardial infarction (NSTEMI).
- The MAPH score's predictive value for thrombus burden in NSTEMI is not well-established.
- This study investigates the MAPH score's prognostic role in estimating coronary thrombus burden in NSTEMI patients.
Purpose of the Study:
- To evaluate the prognostic role of the MAPH score in estimating coronary thrombus burden in NSTEMI patients.
- To determine if the MAPH score can predict high thrombus burden (HTB) in NSTEMI.
- To assess the relationship between MAPH score, low shear rate (LSR), and high shear rate (HSR) with thrombus burden.
Main Methods:
- Patients were categorized into low and high thrombus burden groups.
- Low shear rate (LSR) and high shear rate (HSR) were estimated using hematocrit and serum total protein levels.
- The MAPH score was calculated by summing mean platelet volume (MPV), age, total protein, and hematocrit.
Main Results:
- Patients with high thrombus burden exhibited higher LSR, HSR, and MAPH scores.
- The MAPH score independently predicted high thrombus burden in both adjusted models (Model 1: OR 1.124; Model 2: OR 1.236).
- A MAPH score cutoff of 2 was identified for predicting high thrombus burden.
Conclusions:
- The MAPH score, incorporating MPV, age, total protein, and hematocrit, is a novel and accessible predictor.
- The MAPH score is an independent predictor of high thrombus burden in NSTEMI patients under both LSR and HSR conditions.
Background:
A high thrombus burden has been connected with poor clinical events in patients with non-ST segment elevation myocardial infarction (NSTEMI). In patients with STEMI, a high MAPH score has been associated with a large thrombus burden. However, the predictive value of the MAPH score in determining the thrombus burden in patients with NSTEMI is unclear. The present report aimed to evaluate the prognostic role of the MAPH score in the estimating coronary thrombus burden in NSTEMI patients. The study patients were split into two groups according to their thrombus grade. The low shear rate (LSR) and high shear rate (HSR) were estimated by haematocrit levels and serum total protein levels. The MAPH score was calculated by adding mean platelet volume (MPV) levels and age, in addition to total protein and haematocrit.
Results:
The patients with a high thrombus burden (HTB) had a higher LSR, higher HSR and higher MAPH score compared to patients with low thrombus burden. MAPH score was found to be an independent predictors of HTB in Model 1 (OR: 1.124, 95% CI: 1.011-1.536; p = 0.039) and Model 2 (OR: 1.236; 95% CI: 1.002-1.525; p = 0.047). The cut-off value of the MAPH score for predicting HTB was 2 based on the Youden index.
Conclusions:
The MAPH score, which calculated by adding MPV levels and age, in addition to total protein and haematocrit, is a novel, easily accessible score. The MAPH score at both LSR and HSR was an independent predictor of HTB.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

